The NHGRI grant will fund software development for cancer mutation analysis.
The firm will use the $250,000 fast-track grant to develop its tumor testing system.
The $600,000 award also strengthens Inviragen's ties to UW-Madison. The company's CSO maintains an academic appointment and a research lab within the School of Veterinary Medicine, which has collaborated with Inviragen on other projects.
The bill to reauthorize the science funding programs through 2023 will move to the full Senate.
He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.
In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.